08/21/2024 | Press release | Distributed by Public on 08/21/2024 14:16
Item 5.07 Submission of Matters to a Vote of Security Holders
On August 15, 2024, Neuraxis, Inc. (the "Company") held an annual meeting of stockholders (the "Annual Meeting") at 11611 N. Meridian Street, Suite 330, Carmel, Indiana 46032.
As of the close of business on June 17, 2024, the record date for the Annual Meeting (the "Record Date"), 6,647,960 shares of the Company's common stock, par value $0.001 (the "Common Stock") were outstanding and entitled to vote. At the Annual Meeting, a total of 4,362,195 votes, comprised of shares of the Company's Common Stock, equivalent to approximately 65.61% of the outstanding votes, were represented in person or by proxy at the Annual Meeting, constituting a quorum. The matters that were voted upon at the Annual Meeting, and the number of votes cast for or against/withheld, as well as the number of abstentions and broker non-votes, as to such matters, where applicable, are set forth below.
1. The five nominees for director were elected to serve a one-year term as follows:
Director | Votes For | % Votes For | Votes Withheld | % Votes Withheld | ||||||||||||
Brian Carrico | 3,640,809 | 99.99 | % | 390 | 0.01 | % | ||||||||||
Dr. Christopher R Brown | 3,113,246 | 85.50 | % | 527,953 | 14.50 | % | ||||||||||
Bradley Mitch Watkins | 3,622,864 | 99.50 | % | 18,335 | 0.50 | % | ||||||||||
Beth Keyser | 3,581,615 | 98.36 | % | 59,584 | 1.64 | % | ||||||||||
Kristen Ferge | 3,640,809 | 99.99 | % | 390 | 0.01 | % |
2. The proposal to ratify the appointment of Rosenberg Rich Baker Berman, P.A. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was approved as follows:
Votes For | Votes Against | Broker Non-Votes | Votes Abstained | |||
4,361,643 | 75 | 0 | 477 |
3. The proposal to amend the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan was approved as follows:
Votes For | Votes Against | Broker Non-Votes | Votes Abstained | |||
2,770,781 | 865,918 | 720,996 | 4,500 |
A copy of the second amendment to the Company's 2022 Omnibus Securities and Incentive Plan is attached hereto as Exhibit 10.1 and is incorporated by reference herein.
4. The proposal to amend the Company's Certificate of Incorporation to authorize "blank check" preferred stock was approved as follows:
Votes For | Votes Against | Broker Non-Votes | Votes Abstained | |||
3,523,682 | 117,467 | 720,996 | 50 |
A copy of the amendment to the Company's Certificate of Incorporation is attached hereto as Exhibit 3.1 and is incorporated by reference herein.
5. The proposal of the issuance of 20% or more of Company's outstanding Common Stock upon the conversion of Series B Convertible Preferred Stock or certain convertible promissory notes was approved as follows:
Votes For | Votes Against | Broker Non-Votes | Votes Abstained | |||
3,627,421 | 13,778 | 720,996 | 0 |
A copy of the Company's Certificate of Designation of Series B Convertible Preferred is attached hereto as Exhibit 3.2 and is incorporated by reference herein.
6. The proposal, in a non-binding advisory vote, of the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the SEC was approved as follows:
Votes For | Votes Against | Broker Non-Votes | Votes Abstained | |||
3,609,621 | 26,578 | 720,996 | 5,000 |
7. The proposal to select the frequency of holding the stockholder advisory vote on the Company's executive compensation once every three years was approved as follows:
Every Year | Once Every Two Years | Once Every Three Years | Votes Abstained | |||
918,413 | 574,893 | 2,147,843 | 50 |
8. The proposal of the adjournment of the Annual Meeting was approved as follows:
Votes For | Votes Against | Broker Non-Votes | Votes Abstained | |||
4,317,662 | 44,533 | 0 | 0 |